Daniel S. Bejan

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Moataz Reda, Worapol Ngamcherdtrakul, Molly A. Nelson et al. · Nature Communications · 2022 · 178 citations · Full text

In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response

Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson et al. · Advanced Materials · 2021 · 72 citations · Full text

PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer

Moataz Reda, Worapol Ngamcherdtrakul, Shenda Gu et al. · Cancer Letters · 2019 · 69 citations · Full text

Nanomedicine, Radiation Therapy, Medicine +8

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery

Worapol Ngamcherdtrakul, Thanapon Sangvanich, Moataz Reda et al. · International Journal of Nanomedicine · 2018 · 66 citations · Full text

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2<b>+</b> Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz et al. · Small · 2022 · 47 citations · Full text